Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 4 |
Descriptor
Drug Therapy | 4 |
Pharmacology | 4 |
Advertising | 2 |
Drug Use | 2 |
Intervention | 2 |
Symptoms (Individual… | 2 |
Accreditation (Institutions) | 1 |
Behavior Modification | 1 |
Behavior Problems | 1 |
Biomedicine | 1 |
Children | 1 |
More ▼ |
Source
ProQuest LLC | 4 |
Publication Type
Dissertations/Theses -… | 4 |
Education Level
Higher Education | 1 |
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Baird-Harris, Kay – ProQuest LLC, 2009
Prescription drug direct-to-consumer advertising (DTCA) has been a subject of controversy in recent years. Though government regulations require equivalent prominence of risks and benefits, there is concern about the ability of consumers with limited health literacy to fully comprehend the risks and benefits associated with drug use. Evaluating…
Descriptors: Advertising, Drug Therapy, Drug Use, Pharmacology
Charbonneau, Deborah Hile – ProQuest LLC, 2010
Consumer-targeted prescription drug advertising serves as an interesting lens through which we can examine the portrayal of menopause in online drug advertisements. The aim of this study was to explore the portrayal of menopause on web sites sponsored by pharmaceutical companies for hormone therapies (HT). To unravel this question, a qualitative…
Descriptors: Medical Services, Web Sites, Advertising, Females
Sepulveda, Victoria I. – ProQuest LLC, 2011
Counseling professionals and researchers have advocated for counselor training in psychopharmacology in order to heighten counselors' awareness of client needs and treatment standards (Ingersoll, 2000; King & Anderson, 2004; Smith & Garcia, 2003). There has been a lack of this training within counselor education graduate programs (Buelow, Hebert,…
Descriptors: Counselor Training, Pharmacology, Measures (Individuals), Geographic Regions
Bleiweiss, Jamie – ProQuest LLC, 2009
Problem behavior significantly impedes multiple aspects of quality of life for individuals with developmental disabilities, and thus represents a major priority for intervention. Psychotropic medications are commonly administered to treat such behavior; however, these agents are often associated with adverse side effects that may have a negative…
Descriptors: Intervention, Quality of Life, Developmental Disabilities, Drug Therapy